Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Men's thigh hair grows longer and has a longer growth cycle than women's, but arm hair growth is similar between genders.

Finasteride improves hair density and thickness in women with hair loss.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

The study found an efficient method to extract antioxidants from Hibiscus leaves.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

All three treatments reduce hirsutism, but spironolactone works best long-term.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Obese women with PCOS are more likely to have fatty liver disease.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

The normal range for the hair pull test is 2 hairs or fewer, and washing or brushing hair before the test does not affect the results.

Minoxidil effectively treats female pattern hair loss.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Cyproterone acetate reduced hair growth in most hirsute females and made hair softer, thinner, and lighter.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

New acne treatments show promise as alternatives to traditional therapies.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.